The  Pharma Conclave  is being held in collaboration with the Bulk Drug Manufacturers Association of India, Indian Drug Manufacturers Association  IDMA    TS and AP Chapter and other associations to attract investments in the healthcare and pharmaceuticals sector in Uttar Pradesh. The conference will demonstrate several measures being taken by GoUP to attract healthcare and pharmaceutical companies to the state by rapidly boosting the infrastructure required for the industry and the irresistible incentives for setting up their manufacturing and R&D facilities in the state. 3,000 crore in investments in the pharmaceuticals and medical devices sector and registered a growth of 38.2 per cent in exports between FY16 and FY19.--IANSamita rad Speaking about the event, Mayur Maheshwari, CEO, UPSIDA said,  Government of Uttar Pradesh  GoUP  will be seeking investments from healthcare and pharmaceutical companies from Hyderabad at the conclave. According to the official spokesman, the conference will primarily focus on sensitising industry stakeholders on various incentives offered by the Government of Uttar Pradesh through its Industrial Policy and the Pharmaceutical Policy 2023.The event will also highlight the opportunities in pharmaceutical research and manufacturing, particularly in the upcoming Pharma Park in Lalitpur district and other parks. With a focus on fostering pharmaceutical, generic medicines and medical devices industries in the state, the state government is setting up an exclusive bulk drug park in Lalitpur district with an investment outlay of Rs. Several distinguished pharmaceuticals industry leaders from Hyderabad, will participate in the event to convey their expectations from the Government of Uttar Pradesh.
The Pharma Conclave, held in collaboration with various associations, aims to attract investments in Uttar Pradesh's healthcare and pharmaceuticals sector. The state government offers incentives and infrastructure support to companies setting up manufacturing and R&D facilities, resulting in a 38.2% growth in exports between FY16 and FY19.